Browsing: Raises

OlsAro has raised €5 million in Seed funding to accelerate commercialization of its SeedAX seed genetics platform for developing climate-resilient cereal crops. The round was led by Industrifonden, with Nordic Foodtech VC joining as co-lead. Existing investors Future Food Fund, PINC, AgFunder, and GU Ventures also participated in the financing.

Affinity Labs has raised $2 million in pre-seed funding to expand its portfolio of software products built in partnership with content creators.

San Francisco-based Trissino (Techstars 2025) has raised $1.2M to date to scale Steve AI, an autonomous competitive intelligence agent that helps lean B2B marketing and sales teams track competitors and win more deals.

Pear VC has closed a $333 million Fund V, bringing the early-stage venture firm’s total assets under management to more than $1.1 billion and giving it additional capital to invest primarily in pre-seed and seed-stage startups.

Silvia Bio, a University of Sheffield biotechnology spinout focused on improving the manufacturing of complex biological medicines, has raised £3 million in Seed funding. The round was led by Northern Gritstone, with additional investment from the Parkwalk-managed Northern Universities Venture Fund, the UK Innovation & Science Seed Fund managed by Future Planet Capital, Wren Capital,…

Dream Labs has raised $90 million in seed funding to develop general-purpose AI models designed to control a wide range of robots, while launching what the company describes as the first publicly available API for a robot foundation model. The funding round was led by B Capital and Kindred Ventures, with participation from A.Capital, Unusual…

The Riyadh-based startup is building embedded finance infrastructure for wallets, cards, transfers, payouts and transaction processing.

The Riyadh-based startup is building embedded finance infrastructure for wallets, cards, transfers, payouts and transaction processing.

Sumit Vishwakarma19 Oct 2026 15:02IST New Update

BASEL, Switzerland – October 19, 2026 –Nouscom, a clinical-stage, cancer interception focused biotech developing next-generation immunotherapies, today announced the closing of an oversubscribed €120 million ($135 million) Series D financing. The round was co-led by M Ventures and Revelation Partners alongside new investors Angelini Industries (through Angelini Investments), the European Investment Bank (through Aurea, its…